Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients
Clinical trial NCT04802356 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04802356
- Sponsor
- PETHEMA Foundation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-07
- Primary completion
- 2025-03-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.